Format

Send to

Choose Destination
JAMA Oncol. 2019 Nov 7. doi: 10.1001/jamaoncol.2019.4906. [Epub ahead of print]

Association of Rising Cost and Use of Oral Anticancer Drugs With Medicare Part D Spending From 2013 Through 2017.

Author information

1
Harvard Medical School, Boston, Massachusetts.
2
Harvard Business School, Boston, Massachusetts.
3
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
4
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
PMID:
31697307
PMCID:
PMC6865225
[Available on 2020-11-07]
DOI:
10.1001/jamaoncol.2019.4906

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center